The latest data point to improvements for many cancer types and a continued decline in overall cancer mortality.
Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...
A new Georgia bill could block families from suing some of the companies they say caused the major contamination of forever ...
Q4 2025 Earnings Call February 10, 2026 6:45 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
Japan’s Astellas Pharma announced that it has reached an agreement with Lupin Limited and Lupin Pharmaceuticals to settle pending US patent litigation regarding Astellas’ Myrbetriq (mirabegron), a ...
Anglo-Swedish drugmaker AstraZeneca has announced a positive recommendation from the National Institute for Health and Care Excellence (NICE) for Imfinzi (durvalumab), a perioperative treatment ...
Ever seen a performance so goated that you straight up ignored your bladder because missing even one second was not an option ...
Gilead Sciences (NASDAQ:GILD) executives highlighted what they described as a “remarkable year” of clinical, commercial, and ...